Comparative Pharmacology
Head-to-head clinical analysis: MEDIGESIC PLUS versus PARAFON FORTE DSC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MEDIGESIC PLUS versus PARAFON FORTE DSC.
MEDIGESIC PLUS vs PARAFON FORTE DSC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen inhibits cyclooxygenase (COX) enzymes centrally, reducing prostaglandin synthesis; chlorzoxazone acts centrally as a muscle relaxant via inhibition of polysynaptic reflexes at spinal and subcortical levels.
Chlorzoxazone acts on the central nervous system (CNS) at the spinal cord level, possibly by depressing polysynaptic reflexes, producing skeletal muscle relaxation without affecting neuromuscular transmission.
1-2 tablets orally every 4-6 hours as needed; maximum 8 tablets per day.
Adults: 4 g (500 mg x 8 tablets) orally every 6-8 hours as needed; maximum 8 g (16 tablets) per 24 hours.
None Documented
None Documented
Paracetamol: 2-3 hours. Pseudoephedrine: 5-8 hours (alkaline urine increases half-life). Chlorpheniramine: 12-15 hours in adults. Context: paracetamol half-life prolonged in hepatic impairment; pseudoephedrine/chlorpheniramine half-lives may be prolonged in renal impairment.
1-3 hours (terminal); clinically relevant for dosing intervals of 4-6 hours.
Renal elimination of unchanged drug and metabolites: paracetamol ~90-100% (primarily as glucuronide and sulfate conjugates, ~5% unchanged), pseudoephedrine ~70-90% (mostly unchanged, dependent on urine pH), chlorpheniramine ~30-50% as metabolites. Biliary/fecal: minimal (<5%).
Primarily renal (85-95% as glucuronide conjugates and unchanged drug; <5% fecal).
Category C
Category C
Analgesic Combination
Muscle Relaxant/Analgesic Combination